These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15521111)

  • 1. [The well-informed patient from the statutory health insurance standpoint].
    Wöllenstein H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Oct; 47(10):941-9. PubMed ID: 15521111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?
    Weinhold I; Schindler C; Kossack N; Berndt B; Häckl D
    Eur J Health Econ; 2019 Nov; 20(8):1181-1193. PubMed ID: 31317353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of a large number of health insurance funds and fusions for health services research with statutory health insurance data in Germany - experiences of the lidA study].
    March S; Powietzka J; Stallmann C; Swart E
    Gesundheitswesen; 2015 Feb; 77(2):e32-6. PubMed ID: 25397909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should acupuncture be reimbursed? Three acupuncture programmes of German Statutory Health Insurance Funds (SHI) and their scientific evaluation].
    Linde K
    Z Arztl Fortbild Qualitatssich; 2004 Sep; 98(6):467-8. PubMed ID: 15527186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 6. [External quality assurance of medical rehabilitation in statutory health insurance].
    Kleinfeld A; Barth T; Reiland M
    Z Arztl Fortbild Qualitatssich; 2002 Jan; 96(1):11-6. PubMed ID: 11876043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waiting times in primary care depending on insurance scheme in Germany.
    Luque Ramos A; Hoffmann F; Spreckelsen O
    BMC Health Serv Res; 2018 Mar; 18(1):191. PubMed ID: 29558925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of cross-sectoral treatment models on patients with mental disorders in Germany: study protocol of a nationwide long-term evaluation study (EVA64).
    Neumann A; Swart E; Häckl D; Kliemt R; March S; Küster D; Arnold K; Petzold T; Baum F; Seifert M; Weiß J; Pfennig A; Schmitt J
    BMC Psychiatry; 2018 May; 18(1):139. PubMed ID: 29776348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Declared dead? Recommendations regarding integrated care from the perspective of German statutory health insurance].
    Amelung V; Wolf S; Ozegowski S; Eble S; Hildebrandt H; Knieps F; Lägel R; Schlenker RU; Sjuts R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):352-9. PubMed ID: 25776522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18 months law for the modernisation of the SHI--review and prospects].
    Steinbronn R
    Z Kardiol; 2005; 94 Suppl 4():IV/15-18. PubMed ID: 16416057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disease management programs from a health insurer's point of view].
    Szymkowiak C; Walkenhorst K; Straub C
    Z Arztl Fortbild Qualitatssich; 2003 Jun; 97(3):201-6. PubMed ID: 12856546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Requirements on evidence for system-level decision making regarding the adoption of medical services into the Statutory Health Insurance (SHI) catalogue].
    Lange S; Thomas S
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(8-9):642-7. PubMed ID: 21129701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ambulatory healthcare centres from a legal point of view].
    Jansen C
    Z Arztl Fortbild Qualitatssich; 2006; 100(1):15-9. PubMed ID: 16524223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of physicians: the role of comprehensive private health insurance in Germany.
    Sundmacher L; Ozegowski S
    Eur J Health Econ; 2016 May; 17(4):443-51. PubMed ID: 25924865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Points of view: the role of quality measurement from the Federal Joint Committee's perspective].
    Klakow-Franck R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(8-9):456-64. PubMed ID: 25523843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demands on and benefit from insurance-orientated hospital management - findings from qualitative interviews with executive members of statutory health insurance].
    Hansen H; Lütticke J; Pfaff H
    Gesundheitswesen; 2004 Apr; 66(4):222-31. PubMed ID: 15100938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease management programs in Germany's statutory health insurance system.
    Busse R
    Health Aff (Millwood); 2004; 23(3):56-67. PubMed ID: 15160803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Data sources for continual quality improvement in medical rehabilitation- the QS-Reha procedure of the statutory health insurance funds and the Eva-Reha documentation system of MDK Rhineland-palatinate].
    Bassler M; Nosper M; Follert P; Böwering L; Polak U
    Rehabilitation (Stuttg); 2007 Jun; 46(3):155-63. PubMed ID: 17582556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North].
    Heidbreder M; van Treeck B
    Schmerz; 2019 Oct; 33(5):437-442. PubMed ID: 31531729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.